Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
2.080
+0.240 (13.04%)
At close: Nov 21, 2024, 4:00 PM
2.000
-0.080 (-3.84%)
After-hours: Nov 21, 2024, 5:58 PM EST

Quince Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Selling, General & Admin
15.9115.424.9129.5217.598.95
Upgrade
Research & Development
169.2525.1860.861.3130.21
Upgrade
Operating Expenses
31.924.6450.0990.3278.8939.17
Upgrade
Operating Income
-31.9-24.64-50.09-90.32-78.89-39.17
Upgrade
Interest & Investment Income
3.413.481.070.622.042.19
Upgrade
Currency Exchange Gain (Loss)
00-0.77-0.25--
Upgrade
Other Non Operating Income (Expenses)
-1.24-0.34----
Upgrade
EBT Excluding Unusual Items
-29.74-21.5-49.79-89.95-76.85-36.98
Upgrade
Merger & Restructuring Charges
-2.5-2.5-1.1---
Upgrade
Impairment of Goodwill
-17.13--0.83---
Upgrade
Gain (Loss) on Sale of Assets
-0.04-0.04-0.09---
Upgrade
Asset Writedown
-0.07-5.97-0.14---
Upgrade
Other Unusual Items
-3.66-1.58----
Upgrade
Pretax Income
-53.13-31.58-51.94-89.95-76.85-36.98
Upgrade
Income Tax Expense
0.13-0.2-0.28---
Upgrade
Net Income
-53.26-31.39-51.66-89.95-76.85-36.98
Upgrade
Net Income to Common
-53.26-31.39-51.66-89.95-76.85-36.98
Upgrade
Shares Outstanding (Basic)
433733302919
Upgrade
Shares Outstanding (Diluted)
433733302919
Upgrade
Shares Change (YoY)
18.71%11.17%12.71%1.86%53.30%466.06%
Upgrade
EPS (Basic)
-1.25-0.84-1.54-3.03-2.63-1.94
Upgrade
EPS (Diluted)
-1.25-0.84-1.54-3.03-2.63-1.94
Upgrade
Free Cash Flow
-30.58-18.45-44.17-63.11-50.87-33.33
Upgrade
Free Cash Flow Per Share
-0.72-0.50-1.32-2.12-1.74-1.75
Upgrade
EBITDA
-31.43-24.32-49.89-89.97-78.56-38.98
Upgrade
D&A For EBITDA
0.470.320.20.340.330.19
Upgrade
EBIT
-31.9-24.64-50.09-90.32-78.89-39.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.